Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 1.01, 3.02, 5.02, 8.01, 9.01 · 8-K

MITESCO INC

MITIOTCEQUITYCurrent

Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other Events

Item 1.01 Entry into a Material Definitive Agreement. The Company has entered into an Advisory Agreement with Dawson James Securities allowing them to assist on certain mergers, financing and corporate structuring. The are to receive an issuance of 1,000,000 shares of restricted common stock as consideration, and other fees in the future if successful in specific areas.…

Filed Aug 5, 2026Accepted Aug 4, 2026, 7:31 PM EDTCIK 802257Accession 0001185185-26-003266
Share

Company context

Mitesco, Inc. (the “Company,” “we,” “us,” or “our”) was formed in the state of Delaware on January 18, 2012. On December 9, 2015, we restructured our operations and acquired Newco4pharmacy, LLC, a development stage company which sought to acquire compounding pharmacy businesses. As a part of the restructuring, we shut down our former business line. On April 24, 2020, we changed our name to Mitesco, Inc. In October 2023, the Company changed its domicile from Delaware to Nevada in order to effect reduced costs.

Current securities

Historical securities (7)

Recent company filings

  1. Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsOct 28, 2026
  2. Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsOct 13, 2026
  3. 4 filingSep 17, 2026
  4. SCHEDULE 13D - filed by Valania Brian regarding Mitesco, Inc.Aug 24, 2026
  5. Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Other EventsAug 18, 2026

Disclosure sections

Items 1.01, 3.02, 5.02, 8.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01 Entry into a Material Definitive Agreement. The Company has entered into an Advisory Agreement with Dawson James Securities allowing them to assist on certain mergers, financing and corporate structuring. The are to receive an issuance of 1,000,000 shares of restricted common stock as consideration, and other fees in the future if successful in specific areas. Only the stock issuance is the consideration at this time. A form of the agreement is included herein as Exhibit 10.1.
Item 3.02Item 3.02 - Unregistered Sales of Equity
Item 3.02 Unregistered Sales of Equity Securities. The Board of Directors has authorized the issuance of shares of restricted common stock as follows: The Board of Directors has authorized the issuance of 1,000,000 shares of restricted common stock to five (5) individuals who have been advising the Company for over five (5) years each. These are shareholders who have communicated with the team as the Company has undertaken its restructuring, in regularly, some cases daily. These shares are deemed to be a gift, not compensation and not related to any consulting or other activity. The support from this group of unrelated individuals has been critical to the success and with this action the Board sends their thanks. The Company will take a charge of $35,000 for each of the issuances based on closing price on the date of the issuance, $175,000 in total; The Board of Directors has authorized the issuance of a total of 3,100,000 in aggregate to four (4) individuals who are responsible for its new Robo Agent software application. This issuance, along with smaller previous issuances, will bring the total holdings for each individual to 1,000,000 shares each. The shares are deemed compensation and will result in a charge of $108,500, using a price per share of $.035, the closing price on the date of the issuance; The Board of Directors has authorized the execution of an Advisory Agreement with Dawson James Securities, and with that the issuance of 1,000,000 shares of restricted common stock as compensation. Additional compensation may be earned under the Agreement based on funding, mergers, or other activities. All amounts are within the normal and customary amounts seen in the industry. The expense associated with this issuance is $35,000, no further expense is incurred at this time; The Board of Directors has authorized the issuance of 3,000,000 shares of restricted common stock to Anglo Irish Management, LLC, who has provided consulting and advisory services to the Board of Directors for over 10 years as compensation. The charge for this issuance will be $105,000 using a closing price of $.035 per share; The Board of Directors has awarded each of the members of the Board of Directors 3,000,000 shares of restricted common stock as compensation, at a cost of $105,000 each using a closing price of $.035 per share, at total of $315,000. As a result of these issuances there will be approximately 47,000,000 shares outstanding when all the shares are issued. The securities described have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The Board of Directors has awarded each of the members of the Board of Directors 3,000,000 shares of restricted common stock as compensation, at a cost of $105,000 each using a closing price of $.035 per share, at total of $315,000.
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events. The Company issued a press release on July 28, 2026 discussing its overall strategy. A copy of the press release is included in Exhibit 99.1 of this filing.
Filed exhibits (1)
EX-99.1 (by filename) mitiex99-1.htm

EX-99.1 3 mitiex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Mitesco Provides Business Update on Ai Software, Edge Computing and Strategic Growth Initiatives VERO BEACH, Fla., July 28, 2026 (GLOBE NEWSWIRE) - Mitesco, Inc. (OTCQB: MITI) (“Mitesco” or the “Company”) today announced progress across its artificial intelligence software, distributed edge computing, and strategic growth initiatives as the Company continues to execute its long-term business plan and evaluate strategic acquisition opportunities. The Company currently operates through two primary business segments: its data center subsidiary, Centcore, and its software development division, Vero Technology Ventures (VTV). Centcore initially entered the market through a colocation agreement with a data center facility in Melbourne, Florida. However, the Company exited that arrangement in late 2025 due to operating costs that were no longer competitive within the evolving market environment. In the first quarter of fiscal 2026, Centcore announced a strategic focus on developing and operating smaller-footprint data centers, generally targeting facilities of approximately 10,000 square feet. Building on that strategy, the Compan…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.